Literature DB >> 9278612

Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis.

F J Burt1, R Swanepoel, W J Shieh, J F Smith, P A Leman, P W Greer, L M Coffield, P E Rollin, T G Ksiazek, C J Peters, S R Zaki.   

Abstract

BACKGROUND: Crimean-Congo hemorrhagic fever (CCHF) is a potentially fatal disease that occurs in parts of Africa, Asia, and eastern Europe, and that is caused by a recently emerged bunyavirus. Rapid laboratory diagnosis of CCHF infection is essential and is currently performed by virus isolation and serology. Histopathologic studies have been limited to a small number of cases, and little is known about the cellular tropism of CCHF virus and the pathogenesis of this disease.
DESIGN: We conducted a retrospective case analysis of 12 patients with a diagnosis of CCHF infection, confirmed by virus isolation, who were evaluated at the Special Pathogens Unit, National Institute for Virology, South Africa. The clinicopathologic features of CCHF and the diagnostic role of virus isolation as compared with serology, immunohistochemistry, and in situ hybridization were evaluated. Additionally, the distribution of CCHF virus in human tissues was examined.
RESULTS: The clinical and histopathologic features of CCHF resemble those of other viral hemorrhagic fevers. Of the 12 patients with virus isolation-confirmed CCHF infection, 5 were positive by serology, 10 by immunohistochemistry, and 5 by in situ hybridization. Immunohistochemistry and in situ hybridization analyses showed that the mononuclear phagocytes, endothelial cells, and hepatocytes are main targets of infection. Association of parenchymal necrosis in liver with viral infection suggests that cell damage may be mediated by a direct viral cytopathic effect.
CONCLUSIONS: The diagnosis of CCHF, suspected by history and clinical features, can be supported histopathologically. However, since the pathologic features resemble those of other viral hemorrhagic fevers, an unequivocal diagnosis can be made only by laboratory tests. The utility of immunohistochemistry as a sensitive and rapid diagnostic modality was established by the high degree of concordance with virus isolation. Infection of mononuclear phagocytes, endothelial cells, and hepatocytes may play a critical role in the pathogenesis of CCHF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278612

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  50 in total

1.  Crimean-Congo hemorrhagic fever virus activates endothelial cells.

Authors:  Anne-Marie Connolly-Andersen; Guido Moll; Cecilia Andersson; Sara Akerström; Helen Karlberg; Iyadh Douagi; Ali Mirazimi
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Alterations of serum brain type natriuretic peptide (BNP) in patients with Crimean-Congo hemorrhagic fever.

Authors:  Elif Bilge Uysal; Enver Sancakdar; Ayşe Şeker; Köksal Deveci; Nevin Tuzcu; Hekim Karapınar
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.

Authors:  Michael E Lindquist; Xiankun Zeng; Louis A Altamura; Sharon P Daye; Korey L Delp; Candace Blancett; Kayla M Coffin; Jeffrey W Koehler; Susan Coyne; Charles J Shoemaker; Aura R Garrison; Joseph W Golden
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

4.  Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor.

Authors:  Xiaodong Xiao; Yang Feng; Zhongyu Zhu; Dimiter S Dimitrov
Journal:  Biochem Biophys Res Commun       Date:  2011-06-23       Impact factor: 3.575

Review 5.  Diagnostic Testing for Crimean-Congo Hemorrhagic Fever.

Authors:  Vanessa N Raabe
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

6.  Value of ABO blood group in predicting the severity of children with Crimean-Congo hemorrhagic fever.

Authors:  Ahmet Sami Güven; Enver Sancakdar; Ali Kaya; Elif Bilge Uysal; Mehmet Burhan Oflaz; Fatih Bolat; Hekim Karapınar; Elif Koç; Füsun Dilara Icagasioglu
Journal:  Int J Clin Exp Med       Date:  2014-02-15

7.  Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006-2007.

Authors:  Wun-Ju Shieh; Chris D Paddock; Edith Lederman; Carol Y Rao; L Hannah Gould; Mohamed Mohamed; Fausta Mosha; Janeth Mghamba; Peter Bloland; M Kariuki Njenga; David Mutonga; Amwayi A Samuel; Jeannette Guarner; Robert F Breiman; Sherif R Zaki
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

8.  Imported Crimean-Congo hemorrhagic Fever.

Authors:  Stéphane Jauréguiberry; Pierre Tattevin; Arnaud Tarantola; François Legay; Adama Tall; Pierre Nabeth; Hervé Zeller; Christian Michelet
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

9.  Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model.

Authors:  Dennis A Bente; Judie B Alimonti; Wun-Ju Shieh; Gaëlle Camus; Ute Ströher; Sherif Zaki; Steven M Jones
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

10.  The effect of inflammatory cytokines and the level of vitamin D on prognosis in Crimean-Congo hemorrhagic fever.

Authors:  Emine Parlak; Ayşe Ertürk; Yasemin Çağ; Engin Sebin; Musa Gümüşdere
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.